Enhanced Paracrine FGF10 Expression Promotes Formation of Multifocal Prostate Adenocarcinoma and an Increase in Epithelial Androgen Receptor

Cancer Cell

Volumn 12, Issue 6, 2007, Pages 572-585

  Memarzadeh, Sanaz ^a   Xin, Li ^a   Mulholland, David J ^a   Mansukhani, Alka ^c   Wu, Hong ^a   Teitell, Michael A ^a   Witte, Owen N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLBIO; CELLCYCLE

Indexed keywords

ANDROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GROWTH FACTOR; PROTEIN KINASE B;

ARTICLE; CANCER THERAPY; CARCINOGENESIS; HISTOLOGY; HUMAN; MESENCHYME; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; TUMOR PROMOTION;

EID: 36649036989     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.11.002     Document Type: Article

References (56)

1. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., Washington M.K., Neilson E.G., and Moses H.L. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303 (2004) 848-851
2. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
3. Bostwick D.G., and Foster C.S. Predictive factors in prostate cancer: Current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin. Urol. Oncol. 17 (1999) 222-272
4. Boxer R.B., Jang J.W., Sintasath L., and Chodosh L.A. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6 (2004) 577-586
5. Chen C.D., Welsbie D.S., Tran C., Baek S.H., Chen R., Vessella R., Rosenfeld M.G., and Sawyers C.L. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10 (2004) 33-39
6. Cheng N., Bhowmick N.A., Chytil A., Gorksa A.E., Brown K.A., Muraoka R., Arteaga C.L., Neilson E.G., Hayward S.W., and Moses H.L. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 24 (2005) 5053-5068
7. Chin L., Tam A., Pomerantz J., Wong M., Holash J., Bardeesy N., Shen Q., O'Hagan R., Pantginis J., Zhou H., et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400 (1999) 468-472
8. Culig Z., Hobisch A., Cronauer M.V., Radmayr C., Trapman J., Hittmair A., Bartsch G., and Klocker H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54 (1994) 5474-5478
9. Culig Z., Hobisch A., Bartsch G., and Klocker H. Androgen receptor-An update of mechanisms of action in prostate cancer. Urol. Res. 28 (2000) 211-219
10. Culig Z., Klocker H., Bartsch G., and Hobisch A. Androgen receptors in prostate cancer. Endocr. Relat. Cancer 9 (2002) 155-170
11. Cunha G.R., and Lung B. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J. Exp. Zool. 205 (1978) 181-193
12. Dailey L., Ambrosetti D., Mansukhani A., and Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16 (2005) 233-247
13. Das D., Shah R.B., and Imperiale M.J. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 23 (2004) 7031-7046
14. Dong B., Kim S., Hong S., Das Gupta J., Malathi K., Klein E.A., Ganem D., Derisi J.L., Chow S.A., and Silverman R.H. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. USA 104 (2007) 1655-1660
15. Donjacour A.A., Thomson A.A., and Cunha G.R. FGF-10 plays an essential role in the growth of the fetal prostate. Dev. Biol. 261 (2003) 39-54
16. Doolittle R.F., Hunkapiller M.W., Hood L.E., Devare S.G., Robbins K.C., Aaronson S.A., and Antoniades H.N. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221 (1983) 275-277
17. Faus H., and Haendler B. Post-translational modifications of steroid receptors. Biomed. Pharmacother. 60 (2006) 520-528
18. Feldman B.J., and Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1 (2001) 34-45
19. Feng S., Wang F., Matsubara A., Kan M., and McKeehan W.L. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res. 57 (1997) 5369-5378
20. Foster B.A., Evangelou A., Gingrich J.R., Kaplan P.J., DeMayo F., and Greenberg N.M. Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice. Differentiation 70 (2002) 624-632
21. Freeman K.W., Welm B.E., Gangula R.D., Rosen J.M., Ittmann M., Greenberg N.M., and Spencer D.M. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res. 63 (2003) 8256-8263
22. Gao H., Ouyang X., Banach-Petrosky W.A., Gerald W.L., Shen M.M., and Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc. Natl. Acad. Sci. USA 103 (2006) 14477-14482
23. Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., and Rosen J.M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92 (1995) 3439-3443
24. Harding M.A., and Theodorescu D. Prostate tumor progression and prognosis. Interplay of tumor and host factors. Urol. Oncol. 5 (2000) 258-264
25. Hawley R.G., Lieu F.H., Fong A.Z., and Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1 (1994) 136-138
26. Hill R., Song Y., Cardiff R.D., and Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123 (2005) 1001-1011
27. Huettner C.S., Zhang P., Van Etten R.A., and Tenen D.G. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24 (2000) 57-60
28. Huss W.J., Barrios R.J., Foster B.A., and Greenberg N.M. Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression. Prostate 54 (2003) 8-16
29. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 6 (2006) 392-401
30. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., Han K., DiGregorio G.B., Katzenellenbogen J.A., Katzenellenbogen B.S., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104 (2001) 719-730
31. Kris R.M., Libermann T.A., Avivi A., and Schlessinger J. Growth factors, growth-factor receptors and oncogenes. Nat. Biotechnol. 3 (1985) 135-140
32. Kwabi-Addo B., Ozen M., and Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr. Relat. Cancer 11 (2004) 709-724
33. Li Y., Basilico C., and Mansukhani A. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol. 14 (1994) 7660-7669
34. Lin Y., Liu G., Zhang Y., Hu Y.P., Yu K., Lin C., McKeehan K., Xuan J.W., Ornitz D.M., Shen M.M., et al. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development 134 (2007) 723-734
35. Lu W., Luo Y., Kan M., and McKeehan W.L. Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate. J. Biol. Chem. 274 (1999) 12827-12834
36. Majumder P.K., Yeh J.J., George D.J., Febbo P.G., Kum J., Xue Q., Bikoff R., Ma H., Kantoff P.W., Golub T.R., et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model. Proc. Natl. Acad. Sci. USA 100 (2003) 7841-7846
37. Matsubara A., Kan M., Feng S., and McKeehan W.L. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res. 58 (1998) 1509-1514
38. Nakano K., Fukabori Y., Itoh N., Lu W., Kan M., McKeehan W.L., and Yamanaka H. Androgen-stimulated human prostate epithelial growth mediated by stromal-derived fibroblast growth factor-10. Endocr. J. 46 (1999) 405-413
39. Planz B., Wang Q., Kirley S.D., Marberger M., and McDougal W.S. Regulation of keratinocyte growth factor receptor and androgen receptor in epithelial cells of the human prostate. J. Urol. 166 (2001) 678-683
40. Powers C.J., McLeskey S.W., and Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7 (2000) 165-197
41. Reddy G.P., Barrack E.R., Dou Q.P., Menon M., Pelley R., Sarkar F.H., and Sheng S. Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone-refractory prostate cancer. J. Cell. Biochem. 98 (2006) 1408-1423
42. Sahadevan K., Darby S., Leung H., Mathers M., Robson C., and Gnanapragasam V. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer. J. Pathol. 213 (2007) 82-90
43. Scher H.I., Sarkis A., Reuter V., Cohen D., Netto G., Petrylak D., Lianes P., Fuks Z., Mendelsohn J., and Cordon-Cardo C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin. Cancer Res. 1 (1995) 545-550
44. Seftor E.A., Brown K.M., Chin L., Kirschmann D.A., Wheaton W.W., Protopopov A., Feng B., Balagurunathan Y., Trent J.M., Nickoloff B.J., et al. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Cancer Res. 65 (2005) 10164-10169
45. Shappell S.B., Thomas G.V., Roberts R.L., Herbert R., Ittmann M.M., Rubin M.A., Humphrey P.A., Sundberg J.P., Rozengurt N., Barrios R., et al. Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 64 (2004) 2270-2305
46. Sun M., Yang L., Feldman R.I., Sun X.M., Bhalla K.N., Jove R., Nicosia S.V., and Cheng J.Q. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J. Biol. Chem. 278 (2003) 42992-43000
47. Thomson A.A., and Cunha G.R. Prostatic growth and development are regulated by FGF10. Development 126 (1999) 3693-3701
48. Vukovic B., Park P.C., Al-Maghrabi J., Beheshti B., Sweet J., Evans A., Trachtenberg J., and Squire J. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene 22 (2003) 1978-1987
49. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G.V., Li G., Roy-Burman P., Nelson P.S., et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4 (2003) 209-221
50. Weinstein I.B. Cancer. Addiction to oncogenes-The Achilles heal of cancer. Science 297 (2002) 63-64
51. Wong S., McLaughlin J., Cheng D., Zhang C., Shokat K.M., and Witte O.N. Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations. Proc. Natl. Acad. Sci. USA 101 (2004) 17456-17461
52. Xin L., Ide H., Kim Y., Dubey P., and Witte O.N. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc. Natl. Acad. Sci. USA 100 Suppl 1 (2003) 11896-11903
53. Xin L., Teitell M.A., Lawson D.A., Kwon A., Mellinghoff I.K., and Witte O.N. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc. Natl. Acad. Sci. USA 103 (2006) 7789-7794
54. Zambrano A., Kalantari M., Simoneau A., Jensen J.L., and Villarreal L.P. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53 (2002) 263-276
55. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., and Ornitz D.M. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281 (2006) 15694-15700
56. Zhong C., Saribekyan G., Liao C.P., Cohen M.B., and Roy-Burman P. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res. 66 (2006) 2188-2194